Peter Hollander

17PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersMedical mycologyAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 03, 2024
CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression.

Joana de Matos Rodrigues, Lavanya Lokhande, Lina M Olsson

|Jun 30, 2023
Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma.

Anna Nikkarinen, Lavanya Lokhande, Rose-Marie Amini

|Feb 25, 2023
Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases.

Maysaa Abdulla, Christer Sundström, Cecilia Lindskog

|Jun 24, 2022
LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients.

Karin Paulsen, Millaray Marincevic, Lucia Cavelier

|Mar 18, 2022
Checkpoint CD47 expression in classical Hodgkin lymphoma.

Alex Reza Gholiha, Peter Hollander, Liza Löf

Pageof 3